Recombinant human erythropoietin (r-HuEPO) corrects anemia and prevents transfusion during induction and concurrent chemotherapy during head and neck cancer (HNC) treatment
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S103
- https://doi.org/10.1016/s0959-8049(01)80866-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: